Showing all 8 results
Cefixime & Potassium Clavulanate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative bacilli and Enteric pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefixime and Clavulanic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative bacilli and Enteric pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefixime and Ofloxacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bilayer or Co-Processed Tablet, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/Ph.Eur. 200 mg The Extracellular Specialist: Targets the bacterial cell wall; highly effective against Gram-negative enteric pathogens. Ofloxacin USP/Ph.Eur. 200 mg The Intracellular Specialist: Targets DNA replication; excellent tissue penetration into the lungs, prostate, and urinary tract. Excipients Proprietary Matrix Bilayer Technology: Engineered to prevent physical interaction between the two APIs, ensuring maximum stability and a synchronized release profile in the gut. Cefpodoxime & Clavulanic acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative and Gram-positive pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefpodoxime & Potassium Clavulanate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Protected Tablet, packed exclusively in high-barrier Alu-Alu blister strips to ensure the stability of the highly sensitive Clavulanate payload.
Active Ingredient Strength Primary Clinical Function Cefpodoxime Proxetil USP/Ph.Eur. 200 mg The 3rd-Gen Payload: Broad-spectrum bactericidal activity targeting resistant Gram-negative and Gram-positive pathogens. Potassium Clavulanate Diluted BP/USP 125 mg The Beta-Lactamase Shield: Irreversibly inhibits the enzymes that cause antibiotic resistance. Excipients Proprietary Matrix Moisture-Scavenging Formulation: Engineered specifically utilizing Low-Humidity Processing (RH < 20%). Clavulanic acid is extremely hygroscopic; our tablets use special desiccant-compatible excipients to prevent degradation. Cefuroxime Axetil Tablets
FreeProduct Composition & StrengthWe supply this product as a Precision-Blended, Amorphous Solid Dispersion Tablet, packed exclusively in secure, moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Cefuroxime Axetil USP/Ph.Eur. 250 mg The Pediatric & ENT Anchor: Utilized for Acute Otitis Media, Pharyngitis, and uncomplicated UTIs. Cefuroxime Axetil USP/Ph.Eur. 500 mg The Respiratory Macrodose: Utilized for Community-Acquired Pneumonia, Bronchitis, and early-stage Lyme Disease. Excipients Proprietary Matrix Amorphous Solid Dispersion Technology: Engineered to maintain the API in its highly-soluble amorphous state for maximum clinical cure rates. Cefuroxime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Amorphous Solid Dispersion Tablet, packed exclusively in secure, moisture-resistant Alu-Alu blister strips to ensure the stability of the hygroscopic prodrug.
Active Ingredient Strength Primary Clinical Function Cefuroxime Axetil USP/Ph.Eur.
(Equivalent to Cefuroxime)250 mg The Pediatric & ENT Anchor: The definitive unit utilized for the treatment of Acute Otitis Media, Pharyngitis, and uncomplicated Urinary Tract Infections. Cefuroxime Axetil USP/Ph.Eur. 500 mg The Respiratory Macrodose: The high-efficacy therapeutic payload required for the management of Community-Acquired Pneumonia, Bronchitis, and early-stage Lyme Disease. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Colloidal Silicon Dioxide / Premium Polymeric Film Diluent / Superdisintegrant / Solubilizer / Glidant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion Technology. Because crystalline Cefuroxime Axetil has near-zero bioavailability, our tablets are engineered to maintain the API in its highly-soluble amorphous state for maximum clinical cure rates). *Pack Sizes: 1×6, 1×10, or 10×10 Alu-Alu Blisters (Optimized specifically for strict 5-to-10 day acute curative regimens).
Moxifloxacin & Cefixime Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive antibiotic compounds.
Active Ingredient Strength Primary Clinical Function Moxifloxacin (as Hydrochloride) Ph.Eur./USP 400 mg 4th-Gen Fluoroquinolone: Deep tissue and lung penetration to eradicate DNA replication in resistant respiratory and intra-abdominal pathogens. Cefixime (as Trihydrate) Ph.Eur./USP 400 mg 3rd-Gen Cephalosporin: Massive Gram-negative cell wall destruction, specifically targeting enteric pathogens like Salmonella typhi. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to protect the hygroscopic Cefixime Trihydrate and mask the intensely bitter taste of Moxifloxacin) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 7-to-14 day acute critical-care anti-infective dispensing regimens).
